LAGE3 and neoplasm: An analysis of the survival data revealed that a LAGE3 overexpression was associated with a poor prognosis of OS (p = 0.001) and DFS (Fig. 1A, p = 0.019), while the Gene Expression Profiling Interactive Analysis 2 (GEPIA) database tool also confirmed that LIHC tumor tissues highly expressed LAGE3.